Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice
lacking the LDL receptor.
Authors Johnson LA, Arbones-Mainar JM, Fox RG, Pendse AA, Altenburg MK, Kim HS, Maeda N
Submitted By Nobuyo Maeda on 2/22/2012
Status Published
Journal Diabetes
Year 2011
Date Published 9/1/2011
Volume : Pages 60 : 2285 - 2294
PubMed Reference 21810592
Abstract We investigated the differential roles of apolipoprotein E (apoE) isoforms in
modulating diabetic dyslipidemia-a potential cause of the increased
cardiovascular disease risk of patients with diabetes.

Investigators with authorship
Nobuyo MaedaUniversity of North Carolina